{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T03:43:47Z","timestamp":1777347827364,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park","doi-asserted-by":"publisher","award":["Z191100006619035"],"award-info":[{"award-number":["Z191100006619035"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"DOI":"10.1186\/s12905-026-04413-2","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T03:33:15Z","timestamp":1773977595000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["HPV status as a predictor of ovarian metastasis in cervical adenocarcinoma: implications for surgical decision-making"],"prefix":"10.1186","volume":"26","author":[{"given":"Ming","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianqing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuiqing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"issue":"10224","key":"4413_CR1","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/s0140-6736(20)30068-4","volume":"395","author":"M Brisson","year":"2020","unstructured":"Brisson M, Kim JJ, Canfell K, et al. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet (London England). 2020;395(10224):575\u201390. https:\/\/doi.org\/10.1016\/s0140-6736(20)30068-4.","journal-title":"Lancet (London England)"},{"issue":"2","key":"4413_CR2","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ygyno.2014.11.076","volume":"136","author":"TC Wright","year":"2015","unstructured":"Wright TC, Stoler MH, Behrens CM, et al. Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test. Gynecol Oncol. 2015;136(2):189\u201397. https:\/\/doi.org\/10.1016\/j.ygyno.2014.11.076.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"4413_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, et al. Cancer statistics, 2023. Cancer J Clin. 2023;73(1):17\u201348. https:\/\/doi.org\/10.3322\/caac.21763.","journal-title":"Cancer J Clin"},{"issue":"10167","key":"4413_CR4","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/s0140-6736(18)32470-x","volume":"393","author":"PA Cohen","year":"2019","unstructured":"Cohen PA, Jhingran A, Oaknin A, et al. Cervical cancer. Lancet (London England). 2019;393(10167):169\u201382. https:\/\/doi.org\/10.1016\/s0140-6736(18)32470-x.","journal-title":"Lancet (London England)"},{"issue":"1","key":"4413_CR5","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/AOG.0000000000001754","volume":"129","author":"K Matsuo","year":"2017","unstructured":"Matsuo K, Machida H, Shoupe D, et al. Ovarian Conservation and Overall Survival in Young Women With Early-Stage Cervical Cancer. Obstet Gynecol. 2017;129(1):139\u201351. https:\/\/doi.org\/10.1097\/AOG.0000000000001754.","journal-title":"Obstet Gynecol"},{"issue":"3","key":"4413_CR6","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/j.1525-1438.2007.01054.x","volume":"18","author":"J Pahisa","year":"2008","unstructured":"Pahisa J, Mart\u00ednez-Rom\u00e1n S, Mart\u00ednez-Zamora MA, et al. Laparoscopic ovarian transposition in patients with early cervical cancer. Int J Gynecol cancer: official J Int Gynecol Cancer Soc. 2008;18(3):584\u20139. https:\/\/doi.org\/10.1111\/j.1525-1438.2007.01054.x.","journal-title":"Int J Gynecol cancer: official J Int Gynecol Cancer Soc"},{"issue":"1","key":"4413_CR7","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/0002-9378(92)91828-X","volume":"166","author":"GP Sutton","year":"1992","unstructured":"Sutton GP, Bundy BN, Delgado G, et al. Ovarian metastases in stage \u2160B carcinoma of the cervix: a Gynecologic Oncology Group study. Am J Obstet Gynecol. 1992;166(1):50\u20133.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"4413_CR8","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/j.1525-1438.2006.00854.x","volume":"17","author":"F Landoni","year":"2007","unstructured":"Landoni F, Zanagnolo V, Lovato-Diaz L, et al. Ovarian metastases in early-stage cervical cancer (IA2-IIA): a multicenter retrospective study of 1965 patients (a Cooperative Task Force study). Int J Gynecol cancer: official J Int Gynecol Cancer Soc. 2007;17(3):623\u20138. https:\/\/doi.org\/10.1111\/j.1525-1438.2006.00854.x.","journal-title":"Int J Gynecol cancer: official J Int Gynecol Cancer Soc"},{"issue":"2","key":"4413_CR9","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.ygyno.2005.10.004","volume":"101","author":"M Shimada","year":"2006","unstructured":"Shimada M, Kigawa J, Nishimura R, et al. Ovarian metastasis in carcinoma of the uterine cervix. Gynecol Oncol. 2006;101(2):234\u20137. https:\/\/doi.org\/10.1016\/j.ygyno.2005.10.004.","journal-title":"Gynecol Oncol"},{"issue":"4","key":"4413_CR10","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/s0029-7844(03)00696-3","volume":"102","author":"PG Chan","year":"2003","unstructured":"Chan PG, Sung HY, Sawaya GF. Changes in cervical cancer incidence after three decades of screening US women less than 30 years old. Obstet Gynecol. 2003;102(4):765\u201373. https:\/\/doi.org\/10.1016\/s0029-7844(03)00696-3.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"4413_CR11","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1006\/gyno.1999.5442","volume":"74","author":"N Natsume","year":"1999","unstructured":"Natsume N, Aoki Y, Kase H, et al. Ovarian metastasis in stage IB and II cervical adenocarcinoma. Gynecol Oncol. 1999;74(2):255\u20138. https:\/\/doi.org\/10.1006\/gyno.1999.5442.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"4413_CR12","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.ygyno.2014.12.011","volume":"136","author":"O Touhami","year":"2015","unstructured":"Touhami O, Plante M. Should ovaries be removed or not in (early-stage) adenocarcinoma of the uterine cervix: a review. Gynecol Oncol. 2015;136(2):384\u20138. https:\/\/doi.org\/10.1016\/j.ygyno.2014.12.011.","journal-title":"Gynecol Oncol"},{"key":"4413_CR13","doi-asserted-by":"publisher","first-page":"777","DOI":"10.3389\/fonc.2019.00777","volume":"9","author":"H Cheng","year":"2019","unstructured":"Cheng H, Huo L, Zong L, et al. Oncological outcomes and safety of ovarian preservation for early stage adenocarcinoma of cervix: a systematic review and Meta-analysis. Front Oncol. 2019;9:777.","journal-title":"Front Oncol"},{"key":"4413_CR14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ejogrb.2022.04.012","volume":"273","author":"CJ Violette","year":"2022","unstructured":"Violette CJ, Mandelbaum RS,Bainvoll L, et al. Trends and characteristics of ovarian conservation at hysterectomy for young women with cervical cancer.European. J Obstet Gynecol Reproduct Biol. 2022;273:59\u201364.","journal-title":"J Obstet Gynecol Reproduct Biol"},{"key":"4413_CR15","doi-asserted-by":"publisher","first-page":"408","DOI":"10.12659\/msm.897291","volume":"22","author":"H Lu","year":"2016","unstructured":"Lu H, Li J, Wang L, et al. Is Ovarian Preservation Feasible in Early-Stage Adenocarcinoma of the Cervix? Medical science monitor. Int Med J experimental Clin Res. 2016;22:408\u201314. https:\/\/doi.org\/10.12659\/msm.897291.","journal-title":"Int Med J experimental Clin Res"},{"issue":"3","key":"4413_CR16","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1245\/s10434-012-2632-8","volume":"20","author":"T Hu","year":"2013","unstructured":"Hu T, Wu L, Xing H, et al. Development of criteria for ovarian preservation in cervical cancer patients treated with radical surgery with or without neoadjuvant chemotherapy: a multicenter retrospective study and Meta-analysis. Annals Surg Oncol. 2013;20(3):881\u201390.","journal-title":"Annals Surg Oncol"},{"issue":"3","key":"4413_CR17","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3802\/jgo.2013.24.3.222","volume":"24","author":"T Kato","year":"2013","unstructured":"Kato T, Watari H, Takeda M, et al. Multivariate prognostic analysis of adenocarcinoma of the uterine cervix treated with radical hysterectomy and systematic lymphadenectomy. J Gynecol Oncol. 2013;24(3):222\u20138.","journal-title":"J Gynecol Oncol"},{"issue":"4","key":"4413_CR18","doi-asserted-by":"publisher","first-page":"e4601","DOI":"10.1016\/j.ajog.2016.04.023","volume":"215","author":"J Chen","year":"2016","unstructured":"Chen J, Wang R, Zhang B, et al. Safety of ovarian preservation in women with stage I and II cervical adenocarcinoma: a retrospective study and meta-analysis. Am J Obstet Gynecol. 2016;215(4):e4601\u201313. https:\/\/doi.org\/10.1016\/j.ajog.2016.04.023.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"4413_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13048-016-0301-4","volume":"10","author":"Y Chen","year":"2017","unstructured":"Chen Y, Zhang P, et al. Ovarian preservation in adenocarcinoma of the uterine cervix. J Ovarian Res. 2017;10(1):1\u20135.","journal-title":"J Ovarian Res"},{"issue":"9","key":"4413_CR20","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1038\/sj.bjc.6605048","volume":"11","author":"T Kasamatsu","year":"2009","unstructured":"Kasamatsu T. Onda, T. Sawada M. et al. Radical hysterectomy for FIGO stage I\u2013\u2161B adenocarcinoma of the uterine cervix. Br J Cancer. 2009;100(9):1400-1405.","journal-title":"Br J Cance"},{"key":"4413_CR21","doi-asserted-by":"publisher","unstructured":"Giannella L, Di Giuseppe J, Delli Carpini G, et al. HPV independent adenocarcinomas of the uterine cervix: from molecular characterization to clinical implications. Int J Mol Sci. 2022;23(23). https:\/\/doi.org\/10.3390\/ijms232315022.","DOI":"10.3390\/ijms232315022"},{"issue":"14","key":"4413_CR22","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1200\/jco.21.01930","volume":"40","author":"J Lei","year":"2022","unstructured":"Lei J, Arroyo-M\u00fchr LS, Lagheden C, et al. Human Papillomavirus Infection Determines Prognosis in Cervical Cancer. J Clin oncology: official J Am Soc Clin Oncol. 2022;40(14):1522\u20138. https:\/\/doi.org\/10.1200\/jco.21.01930.","journal-title":"J Clin oncology: official J Am Soc Clin Oncol"},{"issue":"1","key":"4413_CR23","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/his.13995","volume":"76","author":"KJ Park","year":"2020","unstructured":"Park KJ. Cervical adenocarcinoma: integration of HPV status, pattern of invasion, morphology and molecular markers into classification. Histopathology. 2020;76(1):112\u201327. https:\/\/doi.org\/10.1111\/his.13995.","journal-title":"Histopathology"},{"issue":"Suppl 1","key":"4413_CR24","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1097\/PGP.0000000000000751","volume":"40","author":"S Stolnicu","year":"2021","unstructured":"Stolnicu S, Park KJ, Kiyokawa T, et al. Tumor Typing of Endocervical Adenocarcinoma: Contemporary Review and Recommendations From the International Society of Gynecological Pathologists. Int J Gynecol Pathol. 2021;40(Suppl 1):S75\u201391. https:\/\/doi.org\/10.1097\/PGP.0000000000000751.","journal-title":"Int J Gynecol Pathol"},{"issue":"8","key":"4413_CR25","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1016\/j.ejso.2021.04.009","volume":"47","author":"N Bizzarri","year":"2021","unstructured":"Bizzarri N, Pedone Anchora L, Kucukmetin A, et al. Risk of ovarian recurrence after ovarian conservation in early-stage cervical cancer treated with radical surgery: A propensity match analysis. Eur J Surg oncology: J Eur Soc Surg Oncol Br Association Surg Oncol. 2021;47(8):2158\u201365. https:\/\/doi.org\/10.1016\/j.ejso.2021.04.009.","journal-title":"Eur J Surg oncology: J Eur Soc Surg Oncol Br Association Surg Oncol"},{"issue":"5 Suppl 1","key":"4413_CR26","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1097\/LGT.0b013e318287d329","volume":"17","author":"LS Massad","year":"2013","unstructured":"Massad LS, Einstein MH, Huh WK, et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Lower Genit Tract Dis. 2013;17(5 Suppl 1):S1\u201327. https:\/\/doi.org\/10.1097\/LGT.0b013e318287d329.","journal-title":"J Lower Genit Tract Dis"},{"issue":"49","key":"4413_CR27","doi-asserted-by":"publisher","first-page":"9148","DOI":"10.1016\/j.vaccine.2011.09.115","volume":"29","author":"M Seoud","year":"2011","unstructured":"Seoud M, Tjalma WA, Ronsse V. Cervical adenocarcinoma: moving towards better prevention. Vaccine. 2011;29(49):9148\u201358. https:\/\/doi.org\/10.1016\/j.vaccine.2011.09.115.","journal-title":"Vaccine"},{"issue":"9","key":"4413_CR28","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1002\/ijc.33124","volume":"147","author":"D Jenkins","year":"2020","unstructured":"Jenkins D, Molijn A, Kazem S, et al. Molecular and pathological basis of HPV independent cervical adenocarcinoma seen in a global study. Int J Cancer. 2020;147(9):2526\u201336. https:\/\/doi.org\/10.1002\/ijc.33124.","journal-title":"Int J Cancer"},{"issue":"12","key":"4413_CR29","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.5858\/arpa.2016-0356-RA","volume":"141","author":"EC Pirog","year":"2017","unstructured":"Pirog EC. Cervical Adenocarcinoma: Diagnosis of Human Papillomavirus-Positive and Human Papillomavirus-Negative Tumors. Arch Pathol Lab Med. 2017;141(12):1653\u201367. https:\/\/doi.org\/10.5858\/arpa.2016-0356-RA.","journal-title":"Arch Pathol Lab Med"},{"key":"4413_CR30","doi-asserted-by":"publisher","unstructured":"Xing B, Guo J, Sheng Y, et al. Human papillomavirus-negative cervical cancer: a comprehensive review. Front Oncol. 2020;10(606335). https:\/\/doi.org\/10.3389\/fonc.2020.606335.","DOI":"10.3389\/fonc.2020.606335"},{"key":"4413_CR31","doi-asserted-by":"publisher","unstructured":"Yoshida H, Shiraishi K, Kato T. Molecular pathology of human papilloma virus-negative cervical cancers. Cancers. 2021;13(24). https:\/\/doi.org\/10.3390\/cancers13246351.","DOI":"10.3390\/cancers13246351"},{"issue":"3","key":"4413_CR32","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00404-018-4674-z","volume":"297","author":"HY Xu","year":"2018","unstructured":"Xu HY, Tang X, Ding J, et al. Ovarian conservation is associated with better survival in young patients with T1N0M0 cervical adenocarcinoma: a population-based study. Arch Gynecol Obstet. 2018;297(3):775\u201384. https:\/\/doi.org\/10.1007\/s00404-018-4674-z.","journal-title":"Arch Gynecol Obstet"},{"issue":"8","key":"4413_CR33","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1097\/igc.0000000000000780","volume":"26","author":"XB Jiao","year":"2016","unstructured":"Jiao XB, Hu J, Zhu LR. The Safety of Ovarian Preservation in Early-Stage Adenocarcinoma Compared With Squamous Cell Carcinoma of Uterine Cervix: A Systematic Review and Meta-Analysis of Observational Studies. Int J Gynecol cancer: official J Int Gynecol Cancer Soc. 2016;26(8):1510\u20134. https:\/\/doi.org\/10.1097\/igc.0000000000000780.","journal-title":"Int J Gynecol cancer: official J Int Gynecol Cancer Soc"},{"issue":"3","key":"4413_CR34","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1006\/gyno.2001.6447","volume":"83","author":"P Morice","year":"2001","unstructured":"Morice P, Haie-Meder C, Pautier P, et al. Ovarian metastasis on transposed ovary in patients treated for squamous cell carcinoma of the uterine cervix: report of two cases and surgical implications. Gynecol Oncol. 2001;83(3):605\u20137. https:\/\/doi.org\/10.1006\/gyno.2001.6447.","journal-title":"Gynecol Oncol"},{"issue":"5","key":"4413_CR35","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1002\/ijc.31084","volume":"142","author":"K Matsuo","year":"2018","unstructured":"Matsuo K, Shimada M, Yamaguchi S, et al. Identifying a candidate population for ovarian conservation in young women with clinical stage IB-IIB cervical cancer. Int J Cancer. 2018;142(5):1022\u201332. https:\/\/doi.org\/10.1002\/ijc.31084.","journal-title":"Int J Cancer"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-026-04413-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-026-04413-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-026-04413-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T03:14:32Z","timestamp":1777346072000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12905-026-04413-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4413"],"URL":"https:\/\/doi.org\/10.1186\/s12905-026-04413-2","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]},"assertion":[{"value":"2 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"This study was approved by the Institutional Review Board of Beijing Obstetrics and Gynecology Hospital (approval number: 019-KY-104-01), with informed consent waived due to its retrospective design. The procedures of this study followed the ethical standards of the 1964 Helsinki Declaration and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"227"}}